+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cough Suppressant Drugs Market Research Report by Disease Type (Dry Cough and Wet Cough), Drug Type, Age Group, Dosage Form, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 230 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989771
UP TO OFF until Dec 31st 2022
The Global Cough Suppressant Drugs Market size was estimated at USD 1,818.60 million in 2021, USD 1,897.79 million in 2022, and is projected to grow at a CAGR 4.53% to reach USD 2,372.53 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cough Suppressant Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease Type, the market was studied across Dry Cough and Wet Cough.
  • Based on Drug Type, the market was studied across Benzonatate, Butamirate, Codeine, Dextromethorphan, Noscapine, and Pholcodine.
  • Based on Age Group, the market was studied across Adult and Pediatric.
  • Based on Dosage Form, the market was studied across Syrup and Tablet.
  • Based on Distribution Channel, the market was studied across Hospital, Online Pharmacy, and Retail Drug Store.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cough Suppressant Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cough Suppressant Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cough Suppressant Drugs Market, including Acella Pharmaceuticals, LLC, Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Aytu BioScience, Inc., GlaxoSmithKline plc, Mayne Pharma, Inc., Pfizer Inc., Taro Pharmaceutical Industries, Tris Pharma, Inc., and Vernalis plc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cough Suppressant Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cough Suppressant Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cough Suppressant Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Cough Suppressant Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Cough Suppressant Drugs Market?
6. What is the market share of the leading vendors in the Global Cough Suppressant Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Cough Suppressant Drugs Market?
Frequently Asked Questions about the Global Cough Suppressant Drugs Market

What is the estimated value of the Global Cough Suppressant Drugs Market?

The Global Cough Suppressant Drugs Market was estimated to be valued at $1818.6 Million in 2021.

What is the growth rate of the Global Cough Suppressant Drugs Market?

The growth rate of the Global Cough Suppressant Drugs Market is 4.5%, with an estimated value of $2372.53 Million by 2027.

What is the forecasted size of the Global Cough Suppressant Drugs Market?

The Global Cough Suppressant Drugs Market is estimated to be worth $2372.53 Million by 2027.

Who are the key companies in the Global Cough Suppressant Drugs Market?

Key companies in the Global Cough Suppressant Drugs Market include Acella Pharmaceuticals, LLC, Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Aytu BioScience, Inc., GlaxoSmithKline plc, Mayne Pharma, Inc., Pfizer Inc., Taro Pharmaceutical Industries and Vernalis plc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the cases of chronic cough
5.1.1.2. Growing demand for cough suppressant drugs by the consumers
5.1.1.3. Surge in demand from the medical industry
5.1.2. Restraints
5.1.2.1. Side effects associated with the use of cough suppressant drugs
5.1.3. Opportunities
5.1.3.1. Rise in the number of product launches
5.1.3.2. Ongoing research activities in the healthcare sector
5.1.4. Challenges
5.1.4.1. Huge cost associated with treatment and shortage of skilled labor
5.2. Cumulative Impact of COVID-19
6. Cough Suppressant Drugs Market, by Disease Type
6.1. Introduction
6.2. Dry Cough
6.3. Wet Cough
7. Cough Suppressant Drugs Market, by Drug Type
7.1. Introduction
7.2. Benzonatate
7.3. Butamirate
7.4. Codeine
7.5. Dextromethorphan
7.6. Noscapine
7.7. Pholcodine
8. Cough Suppressant Drugs Market, by Age Group
8.1. Introduction
8.2. Adult
8.3. Pediatric
9. Cough Suppressant Drugs Market, by Dosage Form
9.1. Introduction
9.2. Syrup
9.3. Tablet
10. Cough Suppressant Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital
10.3. Online Pharmacy
10.4. Retail Drug Store
11. Americas Cough Suppressant Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cough Suppressant Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
13. Europe, Middle East & Africa Cough Suppressant Drugs Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Acella Pharmaceuticals, LLC
15.2. Amneal Pharmaceuticals, Inc.
15.3. Aurobindo Pharma Limited
15.4. Aytu BioScience, Inc.
15.5. GlaxoSmithKline plc
15.6. Mayne Pharma, Inc.
15.7. Pfizer Inc.
15.8. Taro Pharmaceutical Industries
15.9. Tris Pharma, Inc.
15.10. Vernalis plc
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET DYNAMICS
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2027
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2027
FIGURE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, 2019-2027 (USD MILLION)
FIGURE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (%)
FIGURE 31. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (USD MILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2027
FIGURE 33. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, 2019-2027 (USD MILLION)
FIGURE 36. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (%)
FIGURE 38. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2021 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2027
FIGURE 40. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 45. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, 2019-2027 (USD MILLION)
FIGURE 48. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 49. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 50. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 51. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, 2019-2027 (USD MILLION)
FIGURE 52. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 53. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 55. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 57. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 63. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 64. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2027
FIGURE 65. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 67. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 68. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 69. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 78. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 79. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 80. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 81. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 82. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 83. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 84. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 91. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 92. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 93. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 94. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 95. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 96. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 97. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL COUGH SUPPRESSANT DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 38. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 56. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 59. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2019-2027 (USD MILLION)
TABLE 60. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY STATE, 2019-2027 (USD MILLION)
TABLE 62. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2019-2027 (USD MILLION)
TABLE 65. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY STATE, 2019-2027 (USD MILLION)
TABLE 67. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 70. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2019-2027 (USD MILLION)
TABLE 71. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 73. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 75. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 76. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 80. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2019-2027 (USD MILLION)
TABLE 81. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY STATE, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 85. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 87. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 88. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 89. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 90. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 91. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 92. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 94. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 95. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 96. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 97. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 98. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 100. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 101. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 102. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 103. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 104. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 106. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 107. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 108. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 109. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 110. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 112. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 113. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 114. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 115. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 116. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 118. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 119. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 120. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 121. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 122. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 123. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 125. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 126. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 127. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 129. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 130. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 131. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 132. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 133. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 134. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 135. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 136. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 138. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 139. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 140. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 141. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 142. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 143. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 144. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 145. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 146. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 147. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 148. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 150. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 151. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 152. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 153. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 154. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 155. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 156. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 157. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 158. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 159. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 160. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 161. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 162. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 163. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 164. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 165. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 166. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 167. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 168. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 169. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 170. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 171. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 172. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 173. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 174. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 175. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 176. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 177. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 178. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 179. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 180. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 181. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 182. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 183. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 184. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 185. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 186. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 187. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 188. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 189. TAIWAN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 190. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 191. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 192. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 193. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 194. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 195. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 203. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 204. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 205. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 206. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 207. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 208. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 209. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 210. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 211. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 212. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 213. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 214. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 215. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 216. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 217. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 218. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 219. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 220. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 221. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 222. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 223. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 224. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 225. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 226. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 227. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 228. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 229. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 230. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 231. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 232. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 233. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 234. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 235. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 236. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 237. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 238. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 239. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 240. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 241. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 242. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 243. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 244. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 245. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 246. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 247. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 248. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 249. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 250. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 251. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 252. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 253. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 254. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 255. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 256. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 263. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 264. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2019-2027 (USD MILLION)
TABLE 265. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
TABLE 266. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2019-2027 (USD MILLION)
TABLE 267. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2019-2027 (USD MILLION)
TABLE 268. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 269. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 270. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 271. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 272. GLOBAL COUGH SUPPRESSANT DRUGS MARKET RANKING
TABLE 273. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 274. GLOBAL COUGH SUPPRESSANT DRUGS MARKET MERGER & ACQUISITION
TABLE 275. GLOBAL COUGH SUPPRESSANT DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 276. GLOBAL COUGH SUPPRESSANT DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 277. GLOBAL COUGH SUPPRESSANT DRUGS MARKET INVESTMENT & FUNDING
TABLE 278. GLOBAL COUGH SUPPRESSANT DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 279. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • Acella Pharmaceuticals, LLC
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Aytu BioScience, Inc.
  • GlaxoSmithKline plc
  • Mayne Pharma, Inc.
  • Pfizer Inc.
  • Taro Pharmaceutical Industries
  • Tris Pharma, Inc.
  • Vernalis plc

Methodology

Loading
LOADING...